Companies told to get more creative to secure venture capital
This article was originally published in Scrip
Executive Summary
While venture funds claim to have money to invest in biotechnology, concern that cash spent in the current financial freeze will fail to provide a return in the necessary timeframe is putting the squeeze on investment, delegates heard at the BioTrinity meeting held in Oxford, UK earlier this month.